259 related articles for article (PubMed ID: 6341003)
21. Antimalarial dual drugs based on potent inhibitors of glutathione reductase from Plasmodium falciparum.
Friebolin W; Jannack B; Wenzel N; Furrer J; Oeser T; Sanchez CP; Lanzer M; Yardley V; Becker K; Davioud-Charvet E
J Med Chem; 2008 Mar; 51(5):1260-77. PubMed ID: 18260613
[TBL] [Abstract][Full Text] [Related]
22. Lysis of Plasmodium falciparum by ferriprotoporphyrin IX and a chloroquine-ferriprotoporphyrin IX complex.
Fitch CD; Chevli R; Banyal HS; Phillips G; Pfaller MA; Krogstad DJ
Antimicrob Agents Chemother; 1982 May; 21(5):819-22. PubMed ID: 7049079
[TBL] [Abstract][Full Text] [Related]
23. Parasitological and clinical efficacy of standard treatment regimens against Plasmodium falciparum, P. vivax and P. malariae in Papua New Guinea.
Genton B; Baea K; Lorry K; Ginny M; Wines B; Alpers MP
P N G Med J; 2005; 48(3-4):141-50. PubMed ID: 17212060
[TBL] [Abstract][Full Text] [Related]
24. Atovaquone + proguanil: new preparation. Second-line antimalarial combination.
Prescrire Int; 2002 Oct; 11(61):131-6. PubMed ID: 12378742
[TBL] [Abstract][Full Text] [Related]
25. Regulation of intracellular glutathione levels in erythrocytes infected with chloroquine-sensitive and chloroquine-resistant Plasmodium falciparum.
Meierjohann S; Walter RD; Müller S
Biochem J; 2002 Dec; 368(Pt 3):761-8. PubMed ID: 12225291
[TBL] [Abstract][Full Text] [Related]
26. Accelerated denaturation of hemoglobin and the antimalarial action of chloroquine.
Fitch CD; Russell NV
Antimicrob Agents Chemother; 2006 Jul; 50(7):2415-9. PubMed ID: 16801420
[TBL] [Abstract][Full Text] [Related]
27. Synergistic interaction of a chloroquine metabolite with chloroquine against drug-resistant malaria parasites.
Kalkanidis M; Klonis N; Tschan S; Deady LW; Tilley L
Biochem Pharmacol; 2004 Apr; 67(7):1347-53. PubMed ID: 15013850
[TBL] [Abstract][Full Text] [Related]
28. Interaction of antimalarial drugs with hemin.
Panijpan B; Mohan Rao C; Balasubramanian D
Biosci Rep; 1983 Dec; 3(12):1113-7. PubMed ID: 6365196
[TBL] [Abstract][Full Text] [Related]
29. Hemin lyses malaria parasites.
Orjih AU; Banyal HS; Chevli R; Fitch CD
Science; 1981 Nov; 214(4521):667-9. PubMed ID: 7027441
[TBL] [Abstract][Full Text] [Related]
30. Comparative efficacy and safety of chloroquine and alternative antimalarial drugs: a meta-analysis from six African countries.
Mengesha T; Makonnen E
East Afr Med J; 1999 Jun; 76(6):314-9. PubMed ID: 10750517
[TBL] [Abstract][Full Text] [Related]
31. Potentiation of the antimalarial action of chloroquine in rodent malaria by drugs known to reduce cellular glutathione levels.
Deharo E; Barkan D; Krugliak M; Golenser J; Ginsburg H
Biochem Pharmacol; 2003 Sep; 66(5):809-17. PubMed ID: 12948862
[TBL] [Abstract][Full Text] [Related]
32. Lysis of malarial parasites and erythrocytes by ferriprotoporphyrin IX-chloroquine and the inhibition of this effect by proteins.
Zhang Y; Hempelmann E
Biochem Pharmacol; 1987 Apr; 36(8):1267-73. PubMed ID: 3297071
[TBL] [Abstract][Full Text] [Related]
33. [Ca++ ion transport blockers as reversants of the drug resistance of malarial parasites. 1. The effect of verapamil on the resistance to chloroquine in vivo of Plasmodium berghei and in vitro of Plasmodium falciparum].
Rabinovich SA; Orlov VS; Dadasheva NR; Bukhtin BA; Maksakovskaia EV; Shcherbakov AM; Nguyen VK; Nguyen DS; Vu TT
Med Parazitol (Mosk); 1996; (1):18-22. PubMed ID: 8700004
[TBL] [Abstract][Full Text] [Related]
34. Sensitivity to antimalarial drugs by Plasmodium falciparum in Goundry, Oubritenga province, Burkina Faso.
Del Nero L; Lamizana L; Pietra V; Nebié I
Parassitologia; 1994 Dec; 36(3):287-93. PubMed ID: 7637999
[TBL] [Abstract][Full Text] [Related]
35. [Current therapy and prevention of malaria and perspectives for the future].
Markwalder K
Schweiz Med Wochenschr; 1982 Mar; 112(11):362-8. PubMed ID: 7041253
[TBL] [Abstract][Full Text] [Related]
36. Quinoline-resistance reversing agents for the malaria parasite Plasmodium falciparum.
van Schalkwyk DA; Egan TJ
Drug Resist Updat; 2006; 9(4-5):211-26. PubMed ID: 17064951
[TBL] [Abstract][Full Text] [Related]
37. Antimalarial efficacy and drug interactions of the novel semi-synthetic endoperoxide artemisone in vitro and in vivo.
Vivas L; Rattray L; Stewart LB; Robinson BL; Fugmann B; Haynes RK; Peters W; Croft SL
J Antimicrob Chemother; 2007 Apr; 59(4):658-65. PubMed ID: 17337512
[TBL] [Abstract][Full Text] [Related]
38. Pfmdr1 Asn1042Asp and Asp1246Tyr polymorphisms, thought to be associated with chloroquine resistance, are present in chloroquine-resistant and -sensitive Brazilian field isolates of Plasmodium falciparum.
Póvoa MM; Adagu IS; Oliveira SG; Machado RL; Miles MA; Warhurst DC
Exp Parasitol; 1998 Jan; 88(1):64-8. PubMed ID: 9501850
[TBL] [Abstract][Full Text] [Related]
39. N-cinnamoylation of antimalarial classics: quinacrine analogues with decreased toxicity and dual-stage activity.
Gomes A; Pérez B; Albuquerque I; Machado M; Prudêncio M; Nogueira F; Teixeira C; Gomes P
ChemMedChem; 2014 Feb; 9(2):305-10. PubMed ID: 24474655
[TBL] [Abstract][Full Text] [Related]
40. Interaction of quinoline antimalarial drugs with ferriprotoporphyrin IX, a solid state spectroscopy study.
Asghari-Khiavi M; Vongsvivut J; Perepichka I; Mechler A; Wood BR; McNaughton D; Bohle DS
J Inorg Biochem; 2011 Dec; 105(12):1662-9. PubMed ID: 22079977
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
